When did Monte Rosa Therapeutics, Inc. report Q4 2024 earnings?

Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 2024 earnings on March 20, 2025 before market open.

What were Monte Rosa Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Monte Rosa Therapeutics, Inc. reported revenue of $60.6M and eps of $0.23 for Q4 2024.

Did Monte Rosa Therapeutics, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $46.7M by $14.0M. EPS beat the consensus estimate of $0.02 by $0.21.

Where can I find Monte Rosa Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-042344) directly on SEC EDGAR. The filing index links above go to sec.gov.

Monte Rosa Therapeutics, Inc. GLUE Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Revenue$60.6MBeat by $14.0M

EPS$0.23Beat by $0.21

Revenue estimate$46.7M

EPS estimate$0.02

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$12.9M

EPS estimate-$0.37

Financials

Q4 2024

Income statement

See full

Revenue$60.6M—

Balance sheet

See full

Cash & equivalents$224.3M+75.1%

Total debt$42.7M-7.2%

Total equity$222.9M+24.4%

Total assets$438.7M+44.4%

Cash flow

See full

Operating cash flow$128.9M—

CapEx$183.0K-89.2%

Free cash flow$128.7M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$426.37M+32.6%

Enterprise value$244.83M+2.2%

P/S5.6×—

Profitability

See full

FCF margin50.3%—

Returns & leverage

See full

Debt / equity0.2×-0.1×

Current ratio2.4×-2.7×

Versus estimates

Revenue

Q1 2026$4.2MMiss by $6.8M Q4 2025$2.8MMiss by $12.8M Q3 2025$12.8MMiss by $2.7M Q2 2025$23.2MBeat by $15.4M Q1 2025$84.9MBeat by $71.4M

Q4 2024$60.6MBeat by $14.0M

Diluted EPS

Q1 2026-$0.45Miss by $0.17 Q4 2025-$0.54Miss by $0.19 Q3 2025-$0.33Beat by $0.04 Q2 2025-$0.15Beat by $0.23 Q1 2025$0.57Beat by $0.57

Q4 2024$0.23Beat by $0.21

Ask the moment Monte Rosa Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Monte Rosa Therapeutics, Inc. report Q4 2024 earnings?: Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Monte Rosa Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Monte Rosa Therapeutics, Inc. reported revenue of $60.6M and eps of $0.23 for Q4 2024.
Did Monte Rosa Therapeutics, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $46.7M by $14.0M. EPS beat the consensus estimate of $0.02 by $0.21.
Where can I find Monte Rosa Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-042344) directly on SEC EDGAR. The filing index links above go to sec.gov.